FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

704262001: Siltuximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3010576017 Siltuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010669017 Siltuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010576017 Siltuximab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3010576017 Siltuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010669017 Siltuximab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3010669017 Siltuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
370911000195114 siltuximab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3336331001000115 Siltuximab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
840171000172110 siltuximab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
840171000172110 siltuximab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
370911000195114 siltuximab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3336331001000115 Siltuximab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Siltuximab Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Siltuximab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Siltuximab Inferred relationship Existential restriction modifier (core metadata concept)
Product containing siltuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Siltuximab 400 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Siltuximab Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only siltuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Siltuximab 400 mg powder for solution for injection vial Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Siltuximab 400 mg powder for solution for injection vial Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only siltuximab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing siltuximab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Siltuximab 100 mg powder for solution for infusion and/or injection vial Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1
Siltuximab 100 mg powder for solution for infusion and/or injection vial Has basis of strength substance (attribute) True Siltuximab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start